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Abstract
Most causal inference studies rely on the assumption of overlap to estimate population or
sample average causal effects. When data suffer from non-overlap, estimation of these estimands
requires reliance on model specifications, due to poor data support. All existing methods to
address non-overlap, such as trimming or down-weighting data in regions of poor data support,
change the estimand so that inference cannot be made on the sample or the underlying pop-
ulation. In environmental health research settings, where study results are often intended to
influence policy, population-level inference may be critical, and changes in the estimand can
diminish the impact of the study results, because estimates may not be representative of effects
in the population of interest to policymakers. Researchers may be willing to make additional,
minimal modeling assumptions in order to preserve the ability to estimate population average
causal effects. We seek to make two contributions on this topic. First, we propose a flexible,
data-driven definition of propensity score overlap and non-overlap regions. Second, we develop
a novel Bayesian framework to estimate population average causal effects with minor model
dependence and appropriately large uncertainties in the presence of non-overlap and causal ef-
fect heterogeneity. In this approach, the tasks of estimating causal effects in the overlap and
non-overlap regions are delegated to two distinct models, suited to the degree of data support in
each region. Tree ensembles are used to non-parametrically estimate individual causal effects in
the overlap region, where the data can speak for themselves. In the non-overlap region, where
insufficient data support means reliance on model specification is necessary, individual causal
effects are estimated by extrapolating trends from the overlap region via a spline model. The
promising performance of our method is demonstrated in simulations. Finally, we utilize our
method to perform a novel investigation of the causal effect of natural gas compressor station
exposure on cancer outcomes. Code and data to implement the method and reproduce all simu-
lations and analyses, is available on Github (https://github.com/rachelnethery/overlap).
Keywords: Overlap; Propensity Score; Bayesian Additive Regression Trees; Splines; Natural
Gas; Cancer Mortality.
1 Introduction
1.1 Natural Gas Compressor Stations and Cancer Mortality
During the last several decades, the United States (US) has witnessed a sharp increase in the
incidence of thyroid cancer, which now accounts for 1-1.5% of all newly diagnosed cancer cases
(Pellegriti et al., 2013). Increased exposure of the population to radiation and carcinogenic envi-
ronmental pollutants is blamed, in part, for this increase.
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During the last several decades, US natural gas (NG) production has also increased rapidly.
NG production and distribution systems have recently received attention as a potential source of
human exposure to carcinogenic pollutants and endocrine-disrupting chemicals (Kassotis et al.,
2016). Recent epidemiological studies have found links between NG production and leukemia and
between NG production and thyroid cancer (Finkel, 2016; McKenzie et al., 2017). The relationship
between NG systems and thyroid cancer could be of particular interest due to their coincident rise.
Most previous studies of the health effects of NG systems have focused on associations between
exposure to production sites (e.g., drilling wells) and health outcomes (Finkel, 2016; Rasmussen
et al., 2016; McKenzie et al., 2017). In this study, we turn our attention instead to the potential
health effects of NG distribution systems. Specifically, we aim to provide the first data-driven
epidemiological investigation of the causal effects of proximity to NG compressor stations on thyroid
cancer and leukemia mortality rates.
NG compressor stations are pumping stations located at 40-70 mile intervals along NG pipelines.
They keep pressure in the pipelines so that NG flows in the desired direction (Messersmith et al.,
2015). The operations at compressor stations have raised health concerns for residents of nearby
communities (Southwest Pennsylvania Environmental Health Project, 2015). In this paper, we
exclude from consideration the health impacts of accidents at compressor stations and focus on
the potentially harmful exposures to nearby communities resulting from the normal operations of
compressor stations. Fugitive emissions, or unintended leaking of chemicals from the compressor
station equipment, are known to occur but are not well-characterized. NG compressor stations also
routinely conduct “blowdowns”, in which pipelines and equipment are vented to reduce pressure
(Kloczko, 2015) and any chemicals present in the pipeline are reportedly released into the air in a
30-60 meter plume of gas (Southwest Pennsylvania Environmental Health Project, 2015). Little is
known about the specific types of chemicals emitted.
While airborne emissions from compressor stations are regulated by the EPA under the Clean
Air Act (Messersmith et al., 2015), air quality studies in Pennsylvania and Texas have discovered
harmful chemicals in excess of standards near NG compressor stations (Wolf Eagle Environmen-
tal, 2009; Pennsylvania Department of Environmental Protection, 2010). These chemicals include
methane, ethane, propane, and numerous benzene compounds. Benzene is a known carcinogen
(Maltoni et al., 1989; Golding and Watson, 1999) and many of these compounds are known or
suspected endocrine disruptors (US EPA, 2018).
Motivated by these findings, we present an investigation of the causal effects of compressor
stations on county-level thyroid cancer and leukemia mortality rates. From a sample of 978 coun-
ties from the mid-western region of the US, we obtained their NG compressor stations exposure
status, their thyroid cancer and leukemia mortality rates, and many suspected confounders of this
relationship. While we would like to apply a classic non-parametric causal inference analysis rooted
in the potential outcomes approach (Rubin, 1974), the data exhibit non-overlap, i.e., in some areas
of the confounder space, there is little or no variability in the exposure status of the units. Due to
this non-overlap, any attempt to adjust for confounding when estimating the population average
causal effect must rely upon model-based extrapolation, because we have insufficient data to infer
about missing potential outcomes in those regions of the confounder space. Thus non-parametric
causal inference methods may yield unreliable results.
In this paper, we seek to make two methodological contributions to the causal inference litera-
ture, in the context of the potential outcomes framework. First, we introduce a flexible, data-driven
definition of sample propensity score overlap and non-overlap regions. Second, we propose a novel
approach to estimating population average causal effects in the presence of non-overlap. Using
this approach, the sample is split into a region of overlap (RO) and a region of non-overlap (RN)
and distinct models, appropriate for the amount of data support in each region, are developed
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and applied to estimate the causal effects in the two regions separately. We have found that the
proposed approach leads to improved estimation of the population average causal effects compared
to existing methods. Moreover, we apply this method to estimate the population average causal
effect of compressor station exposure on thyroid cancer and leukemia mortality.
1.2 Causal Inference Notation and Assumptions
We first introduce notation that will be used throughout this article. For subject i, (i = 1, · · ·N),
Y obsi will denote the observed outcome (here it will be assumed to be a continuous random variable,
in Section 2.4 we introduce analogous notation for the binary outcomes setting), Ei will denote
a binary treatment or exposure, and Xi will denote a vector of observed confounders. Under
the stable unit treatment value assumption (Rubin, 1980), potential outcomes Yi(1) and Yi(0),
corresponding to the outcome that would be observed under scenarios Ei = 1 and Ei = 0, re-
spectively, exist for each unit. Only one of these potential outcomes can be observed, such that
Y obsi = EiYi(1) + (1 − Ei)Yi(0). We denote each unit’s missing potential outcome as Y misi , i.e.,
Y misi = (1 − Ei)Yi(1) + EiYi(0). An individual causal effect refers to the difference in poten-
tial outcomes for an individual, i.e., ∆i = Yi(1) − Yi(0). The sample average causal effect is
∆S =
1
N
∑N
i=1 ∆i, the population conditional average causal effect is ∆P |x = E[Y (1) − Y (0)|x],
and the population average causal effect is ∆P = EX [E[Y (1)− Y (0)|X]].
The identifiability of population level causal effects in observational studies typically relies
upon the assumptions of (1) unconfoundedness and (2) positivity. Unconfoundedness implies
that all confounders of the relationship between exposure and outcome are observed, i.e., Ei ⊥
(Yi(1), Yi(0))|Xi. We assume throughout that unconfoundedness holds. Positivity, stated mathe-
matically as 0 < P (Ei = 1|Xi) < 1, is the assumption that each individual has positive probability
of obtaining either exposure status. We also assume that positivity holds, i.e., that each individual
in the population is eligible to receive either exposure status. A number of existing papers dis-
cuss positivity violations (Cole and Herna´n, 2008; Westreich and Cole, 2010; Petersen et al., 2012;
D’Amour et al., 2017).
We relax the assumption of overlap, closely related to positivity, which is required to non-
parametrically estimate sample and population average causal effects. The term overlap refers to
the overlap of the confounder distributions across the exposure groups. Non-overlap occurs when
every unit in the population is eligible to receive either exposure, but, by chance, few or no units
from one exposure group are observed in some confounder strata (Westreich and Cole, 2010). Non-
overlap can be a population level feature or a finite sample issue only. Here, we address problems
arising from finite sample non-overlap, i.e., scenarios in which the population exhibits complete
overlap but, in some areas of the confounder space, data are sparse for one or both exposure
groups, leading to representative samples with non-overlap.
In the presence of non-overlap, sample and population average causal effect estimates generally
suffer from bias and increased variance unless they are able to rely on the additional assumption of
correct model specification (King and Zeng, 2005; Petersen et al., 2012). The overlap assumption
can be evaluated by comparing the empirical distribution of the estimated propensity score, ξˆi =
Pˆ (Ei = 1 |X), between the exposure groups (Rosenbaum and Rubin, 1983; Austin, 2011), assuming
the propensity score is well-estimated. The further assumption that non-overlap is a finite sample
feature only is generally untestable but can sometimes be evaluated using subject-matter expertise.
While the assumption of unconfoundedness becomes more plausible as the number of covariates
grows, the likelihood of non-overlap increases (Cole and Herna´n, 2008; D’Amour et al., 2017); thus,
non-overlap is an increasing problem in our era of high dimensional data.
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1.3 Existing Methods for Estimating Causal Effects in the Presence of Non-
Overlap
Methodological proposals for reducing the bias and variance of causal effect estimates in the presence
of propensity score non-overlap are abundant in the causal inference literature (Cole and Herna´n,
2008; Crump et al., 2009; Petersen et al., 2012; Li et al., 018a); however, to our knowledge, all of the
existing methods modify the estimand and its interpretation so that neither sample nor population
average causal effect estimates can be obtained. In many medical and health research settings, such
as evaluation of treatments, the aim of the research is to help clinicians choose between various
forms of treatment for patients who are likely to adhere to any of the available treatments. In these
contexts, convenience samples are common and modified estimands may be equally informative as or
more informative than sample or population level estimands. However, in the environmental health
applications like the one considered in this paper, study samples are often carefully selected to reflect
a population of interest to policymakers. Here the primary aim is to estimate the burden of disease
attributable to certain contaminants for the whole sample and/or underlying population in order
to ultimately inform regulatory policies. Examples of such applications include the effect of power
plant emissions on cardiovascular hospitalizations (Zigler et al., 2016), the effect of unconventional
natural gas extraction on childhood cancer incidence (McKenzie et al., 2017), and the effect of
gestational chemical exposures on birth outcomes (Ferguson et al., 2014).
The most commonly recommended approach for handling propensity score non-overlap is “trim-
ming” or discarding observations in regions of poor data support (Ho et al., 2007; Petersen et al.,
2012; Gutman and Rubin, 2015). Several papers provide guidance on how to determine which obser-
vations should be trimmed, most in the context of matching (Cochran and Rubin, 1973; LaLonde,
1986; Dehejia and Wahba, 1999; Ho et al., 2007; Crump et al., 2009). An appealing feature of
trimming is its flexibility– it can be applied in conjunction with any causal estimation procedure.
However, trimming allows only for the estimation of the average causal effect in the trimmed sam-
ple. Moreover, trimming changes the asymptotic properties of estimators in ways that are often
overlooked (Yang and Ding, 2018).
Recent methodological developments in the context of weighting approaches to causal inference
may provide more interpretable estimands than trimming. Li et al. (2018a, 2018b) introduce
overlap weights, which weight each member of the sample proportional to its probability of inclusion
in its counterfactual exposure group. The estimand corresponding to the overlap weights is what Li
et al. call the “average exposure effect for the overlap population”, and this overlap population, the
sub-population that contains substantial proportions of both exposed and unexposed individuals,
is of interest in many clinical and public health settings. Zigler and Cefalu (2017) implement a
similar overlap weighting approach in a Bayesian framework.
In contrast to the existing literature, which emphasizes the removal or downweighting of data in
regions of poor support, we propose a method that (1) minimizes model dependence where possible
and (2) performs model-based extrapolation in a principled manner where necessary, yielding esti-
mates of the population level estimand with small bias and appropriately large uncertainty. This
method will be most valuable in environmental health and other applications where preserving
population-level inference in spite of non-overlap is critical.
Our Bayesian modeling approach estimates individual causal effects (∆i) in the RO and the RN
separately. In the first stage of this procedure, a non-parametric Bayesian Additive Regression Tree
(BART) (Chipman et al., 2010), is fit to the data in the RO to estimate causal effects ∆i for each
observation in the RO, where data support is abundant. In the second stage, a spline (SPL) is fitted
to the estimated ∆i in the RO to capture trends in the causal effect surface. The SPL is used to
extrapolate those trends to estimate ∆i for observations in the RN, where insufficient data support
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requires reliance on model specifications/extrapolation. The data in the RN are excluded from all
model fitting, so that the models are not influenced by data-sparse regions; however, after model
fitting to data in the RO, the observed potential outcomes in the RN are employed as covariate
values to aid in prediction of causal effects in the RN, so that we maximally leverage the sparse
data in the RN as well. Because of the flexibility of both BART and SPL, we will show that our
model captures non-linearities and causal effect heterogeneity.
In Section 2, we provide a data-driven definition of the RO and RN, and we introduce our
method, called BART+SPL. Simulations in Section 3 demonstrate how BART+SPL can yield im-
proved population average causal effect estimates relative to existing methods and provide guidance
in specifying tuning parameters. In Section 4, BART+SPL is applied to estimate the effect of NG
compressor station exposure on thyroid cancer and leukemia mortality rates. We conclude with a
summary of our findings in Section 5.
2 Methods
2.1 Definition of Overlap and Non-Overlap Regions
Although King and Zeng (2005) proposed the use of the convex hull of the data to define overlap
and non-overlap regions as early as 2005, this appears to be an unpopular criteria, likely due to its
extreme conservatism. Crump et al. (2009) noted the absence of a systematic definition of the RO
in the causal inference literature. While they offer a definition, their goal is to identify a region of
the data that will produce a minimum variance average causal effect estimate rather than to provide
a general definition of the region where overlap is observed. Their definition may be ideal in the
context of trimming in conjunction with non-parametric causal estimators; however, it is unlikely
to be appropriate in more general settings. BART itself has also been proposed as a method for
identifying the RN (Hill and Su, 2013). Because BART yields relatively large uncertainties for
predicted values of units in regions of poor data support, Hill and Su (2013) suggest trimming
observations with posterior uncertainty values greater than some threshold.
We intend to provide a more general characterization of the RO and RN here. We use the
estimated propensity scores, ξˆi, to define the RO, O, and the RN, O
⊥, in the sample. Throughout
this section, we assume that the propensity score model has been correctly specified (or that
the true propensity score is known, in which case ξi can be substituted for ξˆi in the following);
however, we demonstrate and discuss the performance of our method under propensity score model
misspecification using simulations in Section 3. Let ξˆ(j) denote the j
th order statistic of the ξˆi and
P =
[
ξˆ(1), ξˆ(N)
]
be the subspace of (0, 1) over which the ξˆi are observed.
Our definition allows every point in P to be assigned to either O or O⊥. The user must pre-
specify two parameters, denoted a and b, which are used to identify O. O⊥ is then defined as the
complement of O, relative to P . Consider any point o ∈ P . The idea behind our definition of
overlap is that, if more than b units from each exposure group have estimated propensity scores
lying within some open interval of size a covering o, then o is included in the region of overlap.
Thus, a is an interval length, i.e., a portion of the range of the estimated propensity score, and b
is a portion of the sample size, representing the number of estimated propensity scores from each
exposure group that must lie sufficiently close, i.e., within an interval of length a, to any given
point in order for the point to be added to the RO. Framing this definition in a way that can
be operationalized, it says that there is sufficient data support (overlap) at a point o if, for each
exposure group separately, we can form a set that includes (1) o and (2) more than b estimated
propensity scores and lies entirely within an interval of size less than a, i.e., has range less than a.
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We now introduce notation that will be used in the definition. Let Ne denote the number of
units in exposure group e and ξˆe(i) denote the i
th propensity score order statistic in exposure group
e. Using this notation, we propose the following definition for the region of overlap:
O =
{
o ∈ P : for e = 0, 1, range(
{
o, ξˆe(i), ..., ξˆ
e
(i+b)
}
) < a for some i = 1, ..., Ne − b
}
This formalizes the notion introduced above of finding a set of o and more than b propensity scores,{
o, ξˆe(i), ..., ξˆ
e
(i+b)
}
, with range less than a for each exposure group.
In comparison with previous definitions, our overlap definition provides a flexible, transparent,
and data-driven approach to identifying regions of poor data support, with relatively easy-to-
understand tuning parameters that give users the ability to decide what constitutes “sufficient”
data support in the context of their own methods and application. Another contribution of this
overlap definition to the wider literature is that it allows for regions of non-overlap in the interior
of the propensity score distribution. In Figure 2 in Section A.3 of the Appendix, we provide an
illustration of the types of non-overlap that can be captured by this definition.
We define the RO and RN for BART+SPL using this definition. However, we note that
BART+SPL is designed to handle exclusively non-overlap in the tails of the propensity score distri-
bution. In Section 3.3, we provide guidance on how to specify a and b when applying BART+SPL.
2.2 Tree Ensembles for Causal Inference
Regression trees are a class of non-parametric machine learning procedures, primarily used for
prediction, in which a model is constructed by recursively partitioning the covariate space. Tree
ensemble methods like BART (Chipman et al., 2010) gained popularity as a more stable generaliza-
tion of regression trees. Appealing features of tree ensembles include (1) their internal construction
of the model, eliminating the need to pre-specify the functional form of the association between the
response and predictors and (2) their ability to capture complex non-linear associations and high
order interactions (Strobl et al., 2009).
BART is highly regarded for its consistently strong performance under the “default” model
specifications, reducing its dependence on subjective tuning and time consuming cross validation
procedures. Letting j index the J trees in the ensemble (j = 1, ..., J), a BART is a sum of trees
model of the form
Y =
J∑
j=1
g(X; Tj ,Mj) + , (1)
where g is a function that sorts each unit into one of a set of mj terminal nodes, associated with
mean parametersMj = {µ1, ..., µmj}, based on a set of decision rules, Tj .  is a random error term
that is typically assumed to be N(0, σ2) when the outcome is continuous. BART has also been
extended to the binary outcome setting through the addition of the probit link function. BART’s
strong predictive performance has been reported in many contexts (Zhou and Liu, 2008; He et al.,
2009; Chipman et al., 2010; Liu et al., 2010; Bonato et al., 2011; Hill, 2011; Huang et al., 2015; Liu
et al., 2015; Kindo et al., 2016; Sparapani et al., 2016).
BART was first introduced as a tool for causal inference by Hill (2011), who suggested fitting
a BART, including the estimated propensity score as a covariate, and using it to predict missing
potential outcomes. Despite BART’s highly accurate potential outcome prediction in regions of
the data with strong support, its predictions have been shown to sometimes contain greater bias
than those of parametric and classic causal inference approaches in the presence of non-overlap
(Hill, 2011; Hill and Su, 2013). Because BART relies on binary cuts of the observed predictors, it
is unable to capture trends in the data and therefore extrapolates poorly.
6
2.3 BART+SPL
In this section, we describe BART+SPL, our proposed Bayesian approach for estimating causal
effects in the presence of propensity score non-overlap. The first stage of the procedure, which we
call the imputation phase, utilizes a BART to impute the missing potential outcomes and estimate
individual causal effects in the RO. In the second stage, which we call the smoothing stage, a spline
is fit to the BART-estimated individual causal effects in the RO and is invoked to extrapolate the
causal effect trends to the individuals in the RN, leveraging the information from the observed
potential outcomes for observations in the RN. Our approach for continuous outcomes is described
in Sections 2.3.1 and 2.3.2 in the context of a single iteration of a Bayesian MCMC sampler for
the sake of clarity, and in Section 2.3.3, we explain how the draws from the sampler can be invoked
to estimate causal effects and associated uncertainties. This model can be implemented through
the MCMC procedure described in Section A.1 of the Appendix. In Section 2.4, we introduce an
extension to binary outcomes.
2.3.1 Imputation Stage
In the first stage of BART+SPL, we adopt the common practice of treating the unobserved potential
outcome for each individual as missing data, and we construct a BART model to impute these
missing values for individuals in the RO. We introduce the subscripts q and r to index data from
subjects in the RO and RN, respectively, e.g., Y obsq is the observed outcome of individual q in the
RO and Y misr is the missing potential outcome of individual r in the RN (q = 1, ..., Q; r = 1, ..., R).
Subscript O and subscript O⊥ refer to vectors/matrices of the values of all individuals in O and
O⊥, respectively, e.g., YmisO =
[
Y mis1 , ..., Y
mis
Q
]′
and Ymis
O⊥ =
[
Y mis1 , ..., Y
mis
R
]′
.
In this stage, all of our modeling efforts are focused on the data in the RO. Y misq is first imputed
using a BART model of the form
Y obsq =
J∑
j=1
g(Eq, ξˆq,Xq; Tj ,Mj) + q,
where q ∼ N(0, σ2B). To do so, the Bayesian backfitting algorithm of Chipman et al. (2010)
is utilized to collect a sample from the posterior distribution of θ = {σ2B, Tj ,Mj ; j = 1, ..., J},
p(θ|YobsO ). An imputed value of YmisO , denoted Y˜misO , is obtained by sampling from its posterior
predictive distribution (ppd), p(YmisO |YobsO ) =
∫
p(YmisO |YobsO , θ)p(θ|YobsO )dθ. YobsO and Y˜misO are
used to construct a sample of the individual causal effects in O, ∆˜O.
2.3.2 Smoothing Stage
In the second stage, a smoothing model is fit to the BART-estimated individual causal effects in the
RO, and the model is employed to estimate the individual causal effects in the RN by extrapolating
the trends identified in the RO. With this approach, we impose the assumption that any trends in
the individual causal effects (as a function of the propensity score and/or the covariates) identified in
the RO can be extended into the RN. By modeling the causal effect surface in this stage rather than
the separate potential outcome surfaces, we take advantage of the potentially increased smoothness
of the causal effects that may occur in practice. Through tuning, we ensure that the variance in the
RN is inflated to reflect the high uncertainty in the region, leading to mildly conservative confidence
regions in most realistic scenarios.
Assume for now that the RN includes only exposed individuals so that Er = 1 for all r. Define
Y ∗q (1) = Y obsq if Eq = 1 and Y ∗q (1) = Y˜ misq otherwise (remember Y˜ misq denotes the BART-imputed
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missing potential outcome for q). Thus, Y ∗q (1) is the observed or imputed potential outcome
corresponding to E = 1 for each unit in the RO. Let rcs(z) denote a restricted cubic spline basis
for z. Employing the imputed values obtained in the previous stage, we construct the following
smoothing stage model:
∆˜q = W
′β + q, W =
 rcs(ξˆq)rcs(Y ∗q (1))
Xq
 ,
where q ∼ N(0, σ2S + I(ξˆq ∈ O⊥)τq). σ2S is the residual variance for all units in the RO and τq
is an added variance component only applied to units in the RN. The purpose of τq is to inflate
the variance of units with an estimated propensity score in the RN, to adequately reflect the
higher uncertainty in regions of little data support. In this model, τq is clearly unidentifiable, as
the model is fit using exclusively data in the RO, and it will only come into play when invoking
the ppd to predict in the RN. Here, we choose to treat it as a tuning parameter, and below we
describe our recommended tuning parameter specification. We recommend restricted cubic splines
in the smoothing model, because they generally demonstrated superior performance when applied
to simulated data, however other spline choices may provide improved performance under some
conditions. We also recommend excluding a small portion of the data at the tails of the RO
(i.e., tails of the propensity score in the RO) from spline model fitting, either through the use of
boundary knots or by omitting these data from the model, because BART’s predictions in the tails
of variables can be unstable and can negatively influence the SPL’s performance.
We collect a posterior sample of the spline parameters, ψ = {β, σ2S}. Recall the motivation for
the smoothing stage is to use the trends from the RO to predict the individual causal effects in
the RN. Thus, the sampled ψ and the covariate values for individuals in the RN are summoned to
obtain a sample from the ppd of ∆O⊥ , p(∆O⊥ |∆O) =
∫
p(∆O⊥ |∆O, ψ)p(ψ|∆O)dψ. The sample is
denoted ∆˜O⊥ .
Note that including Y ∗q (1) as a predictor permits the model to capture the relationship between
the causal effects and Y (1), the potential outcome observed for all units in the RN. This allows
the observed potential outcomes in the RN to aid in the extrapolation, so that this information is
not wasted. In the case that both exposed and unexposed units fall in the RN, we define Y ∗q (0)
analogously to Y ∗q (1) and construct a second model, identical to the one above except replacing
rcs(Y ∗q (1)) with rcs(Y ∗q (0)). The ppd from the first model is then used to predict individual causal
effects for exposed units in the RN and the ppd from the second model is used for unexposed units.
Our recommended specification of τq is motivated by the aim to have (1) the variance of individ-
ual causal effects increase monotonically as the observation’s distance from the RO (i.e., region of
strong data support) increases and (2) the increase in variance be in proportion to the scale of the
data. Thus, the suggested tuning parameter specification is τq = (10dq)tO, where tO = range(∆˜O)
and dq is the distance from the observation’s propensity score to the nearest propensity score in
the RO. The effect of this tuning parameter is that, for every .1 unit further we go into the RN, the
variance of the individual causal effects increases by the range of the causal effects in the RO. While
it could lead to somewhat conservative credible interval coverage in “simple” situations (e.g., when
the trends in the RN are easily predicted from the trends in the RO), we have found in simulations
that this choice of tuning parameter consistently provides both reasonably-sized credible intervals
and acceptable coverage.
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2.3.3 Estimation and Uncertainty Quantification
We can iterate the two stages described above M times to obtain
{
∆
(1)
O , ...,∆
(M)
O
}
from the impu-
tation stage and
{
∆
(1)
O⊥ , ...,∆
(M)
O⊥
}
from the smoothing stage (note that we have traded the tilde
notation from above for the (m) notation to differentiate the samples from the M iterations). By
iterating between the two stages, we are able to account for the uncertainty in the estimation of
∆O from the first stage and pass it on to the second stage, where ∆O is used as the outcome. Thus,
the uncertainty in the estimate of ∆O⊥ reflects the uncertainty both from stage one and stage two.
For units in the RO and the RN, individual causal are estimated as ∆ˆq =
1
M
∑M
m=1 ∆
(m)
q and
∆ˆr =
1
M
∑M
m=1 ∆
(m)
r , respectively, i.e., the posterior mean over the M samples. Credible intervals
for the individual causal effects can be obtained by extracting the appropriate percentiles from these
M samples. Samples of ∆S are produced by ∆
(m)
S =
1
N (
∑Q
q=1 ∆
(m)
q +
∑R
r=1 ∆
(m)
r ) for m = 1, ...,M ,
and ∆ˆS =
1
M
∑M
m=1 ∆
(m)
S . As above, percentiles of the M samples provide credible interval for ∆S .
In order to estimate ∆P , an additional integration over the predictors is required. Wang et al.
(2015) discuss the necessity of such an integration step when estimating population average causal
effects with models that permit non-linearity and/or heterogeneity, and they propose the application
of the Bayesian bootstrap to execute it. We adopt the same approach here. For each sample of the
individual causal effects,
{
∆
(m)
O ,∆
(m)
O⊥
}
, the Bayesian bootstrap is performed on it B times (where
B is a large constant) and the average of each bootstrap sample taken to obtain B draws from
the posterior distribution of the population average causal effect. We randomly select one of these
samples and call it ∆
(m)
P , so that in the end we have collected
{
∆
(1)
P , ...,∆
(M)
P
}
. The population
average causal effect is estimated as ∆ˆP =
1
M
∑M
m=1 ∆
(m)
P and the credible interval formed using
percentiles.
2.4 BART+SPL with Binary Outcomes
By invoking BART probit (Chipman et al., 2010) in the imputation stage and utilizing a simple
arcsine transformation in the smoothing stage, we can straightforwardly extend BART+SPL to the
binary outcomes setting. While most of our notation will remain the same for binary outcomes,
we note a few changes. Individual causal effects are traditionally defined as the difference in each
individual’s potential outcomes, as above; however, in the binary outcomes setting, estimating
those differences, which can only take on values -1, 0 and 1, may be challenging and may sacrifice
information. Because, in our approach, we are treating the potential outcomes as random variables,
it is reasonable and desirable to instead define the individual causal effects as differences in some
features of the distributions of the potential outcomes, although doing so requires a slight abuse
of traditional terminology/notation. For binary outcomes, we define the individual causal effects
as ∆i = P (Yi(1) = 1) − P (Yi(0) = 1) and the estimands as ∆S = 1N
∑N
i=1 ∆i, ∆P |x = P (Y (1) =
1|x) − P (Y (0) = 1|x), and ∆P = EX [P (Y (1) = 1|X) − P (Y (0) = 1|X)]. Here we fit a BART
probit to estimate individual causal effects in O, fit a spline model to the arcsine transform of these
estimates (which are bounded between -1 and 1), and use the spline to estimate individual causal
effects for units in O⊥. While we provide below explicit forms for the imputation and smoothing
models in the binary setting, we refer the reader back to the previous section for the full sampling
procedure details, which follow analogously to the continuous outcomes setting.
9
In the imputation stage, the BART probit model fit to the RO data has the following form:
P (Y obsq = 1) = Φ(
J∑
j=1
g(Eq, ξˆq,Xq; Tj ,Mj)),
where Φ() is the standard Normal cumulative distribution function. With this model, posterior
samples P˜ (Y obsq = 1) and P˜ (Y
mis
q = 1) can be drawn and used to form a posterior sample of the
individual causal effect, ∆˜q.
For the smoothing stage, as above, assume without loss of generality that all the units in O⊥
all have Er = 1. Define Y
∗
q (1) = Y
obs
q if Eq = 1 and Y
∗
q (1) = I(P˜ (Y
mis
q = 1) > 0.5) otherwise.
Then the smoothing model is
arcsine(∆˜q) = W
′β + q, W =
 rcs(ξˆq)Y ∗q (1)
Xq
 ,
where q ∼ N(0, σ2S). Note that, unlike in the continuous case, no tuning parameter is included
in the variance, as simulations indicated it was not needed to obtain reasonable coverage in the
binary setting. Individual causal effects on the arcsine scale for units in O⊥ can be obtained from
the posterior predictive distribution and back-transformed to the desired scale. As described in the
previous section, a second analogous smoothing model can be fit if O⊥ contains units from both the
exposed and unexposed groups. Average causal effect estimation and uncertainty quantification
proceed identically to the continuous case.
3 Simulations
In this section, we conduct simulation studies to evaluate the performance of BART+SPL relative
to existing methods in the presence of non-overlap and to provide guidance on how to specify
parameters a and b in the non-overlap definition to obtain optimal performance. In Section 3.1,
we simulate data with a small number of confounders and varying degrees of non-overlap, and
we compare BART+SPL’s population average causal effect estimation performance to that of a
standard BART and of an existing spline-based method for causal inference. In Section 3.2, we
generate data with non-overlap and high dimensional covariates and compare the performance of
BART+SPL and the spline-based method. Finally, data with varying amounts of non-overlap are
generated and BART+SPL is implemented with various specifications of a and b to provide insight
on the optimal choices in Section 3.3. R code (R Core Team, 2016) to implement BART+SPL and to
reproduce all simulations is available on Github at https://github.com/rachelnethery/overlap.
3.1 Performance of BART+SPL Relative to Existing Methods
We purposely simulate data under a challenging situation of: a) propensity score non-overlap; b)
non-linearity of the potential outcomes in the propensity score; and c) heterogeneous causal effects.
We wish to evaluate the relative performance of our method when utilizing a true propensity
score and when utilizing a misspecified propensity score estimate. We first discuss the simulation
structure when utilizing the true propensity score. We let N = 500 and assign half of the subjects to
E = 1. We generate two confounders that are highly associated with the exposure (E), one binary
(X1 : X1|E = 1 ∼ Bernoulli(.5), X1|E = 0 ∼ Bernoulli(.4)) and one continuous (X2 : X2|E =
1 ∼ N(2 + c,√1.25 + 0.1c), X2|E = 0 ∼ N(1, 1)). Given these specifications, the true propensity
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scores can easily be calculated using Bayes Rule. The potential outcomes are constructed as
Yi(1) = −3(1 + exp(−(10(X2i − 1)))−1 + 0.25X1i − X1iX2i and Yi(0) = −1.5X2i. We label the
simulations with the true propensity score as 3.1A.
For the simulations with a misspecified propensity score estimate, we again let N = 500 and
assign half of the subjects to E = 1. We generate a binary confounder (X1 : X1|E = 1 ∼
Bernoulli(.5), X1|E = 0 ∼ Bernoulli(.4)) and a continuous confounder (X2 : X2|E = 1 ∼ N(2 +
c, 4), X2|E = 0 ∼ N(1, 1)). The potential outcomes are Yi(1) = 3(1 + exp(−(10(X2i − 1)))−1 +
0.25X1i−0.1X1iX2i+0.5 and Yi(0) = 0.2X2i+0.1X22i+1. As is common in the literature, we use a
simple logistic regression model of the form logit(P (Ei = 1)) = β0 + β1X1i + β2X2i to estimate the
propensity scores. This model is clearly misspecified, because, for example, the true relationship
between E and X2 is not linear. In practice, when the form of the propensity score model is
unknown, we encourage the use of flexible models for estimation (Westreich et al., 2010), such as
BART, neural networks, or support vector machines, in order to reduce the chance of propensity
score model misspecification. The use of BART for propensity score estimation is demonstrated
in the application to real data in Section 4. Various flexible propensity score estimation methods
could be tested and the method that achieves the best covariate balance selected. We label the
simulations with the misspecified propensity score as 3.1B.
We have selected these simulation structures so that, for a single value of c, the type and
degree of propensity score non-overlap in 3.1A and 3.1B should be similar. Both 3.1A and 3.1B
produce data sets with lack of overlap in the right tail of the propensity score distribution (i.e.,
individuals from the unexposed group are unobserved or very sparse), and with varying degrees of
non-overlap controlled by c. Our simulations are designed to produce non-overlap in the right tail
of the propensity score distribution and our motivation is to demonstrate how our method performs
in the presence of different features in this RN. Thus, simulated datasets are utilized in the results
below only if any intervals of non-overlap outside the right tail contain 10 observations or fewer
(cumulatively), and, in these datasets, the intervals of non-overlap outside the right tail are ignored
(i.e., treated as part of the RO). In this way, we ensure that the results solely reflect how the tested
methods respond to the features of the intended RN.
We consider three separate simulated scenarios, i.e. three different specifications of c, within
3.1A and 3.1B. We let c = 0 (simulations 3.1A-i and 3.1B-i), c = 0.35 (simulations 3.1A-ii and
3.1B-ii), and c = 0.7 (simulations 3.1A-iii and 3.1B-iii). Example datasets from each are illustrated
in Figure 3 in Section A.3 of the Appendix. With c = 0, the RN is quite small, and the trend in the
individual causal effects in the RN is mildly non-linear. With c = 0.35, the RN is somewhat larger
and the trends exhibited by the individual causal effects in the RN are moderately non-linear. With
c = 0.7, a substantial portion of the sample lies in the RN and the causal effects in the RN are
highly non-linear. We use our definition of overlap with a = .1 and b = 7 to define the RO and RN
for each simulated dataset.
We implement BART+SPL on 1,000 simulated datasets under each condition. Gutman and
Rubin (2015) recommended a spline-based multiple imputation approach for estimating average
causal effects. They also suggest trimming in conjunction with their method for samples suffering
from non-overlap. We compared the performance of BART+SPL versus Gutman and Rubin’s
method both with and without trimming (T-GR and U-GR, respectively) and also BART with
and without trimming (T-BART and U-BART, respectively). Detailed results of the untrimmed
analyses appear in Table 1 and the distributions of the average causal effect estimates from the
trimmed and untrimmed analyses can be compared in Figure 4 in Section A.3 of the Appendix.
The simulation results demonstrate the dominant performance of BART+SPL compared to
U-BART and U-GR under a wide range of challenging conditions. However, in extreme scenarios
with unpredictable trends and large portions of the sample in the RN, even the performance of
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BART+SPL may deteriorate, as demonstrated by simulation 3.1A-iii, where BART+SPL gives high
percent bias, and simulation 3.1B-iii, where BART+SPL gives high percent bias and poor coverage.
Nonetheless, BART+SPL’s performance still exceeds that of its competitors. For both BART and
GR, the trimmed estimates, which are no longer estimators of the population level causal effects,
are further from the true population average causal effects than the untrimmed estimates.
Table 1: Absolute (Abs) bias, 95% credible interval coverage and mean square error (MSE) in
estimation of the population average causal effects in simulations from Section 3.1.
Simulation Setting Method Abs Bias Abs Bias (%) Coverage MSE
3.1A-i
U-GR 0.12 46.46 0.33 1.25
U-BART 0.03 10.72 0.99 0.07
BART+SPL 0.01 5.63 1.00 0.05
3.1A-ii
U-GR 0.17 97.31 0.23 1.69
U-BART 0.05 31.95 0.89 0.12
BART+SPL 0.02 12.58 1.00 0.09
3.1A-iii
U-GR 0.23 724.78 0.19 2.34
U-BART 0.08 427.55 0.71 0.22
BART+SPL 0.03 100.80 1.00 0.14
3.1B-i
U-GR 0.26 50.42 0.00 0.64
U-BART 0.13 25.47 0.12 0.33
BART+SPL 0.11 21.64 0.62 0.27
3.1B-ii
U-GR 0.32 66.58 0.00 0.73
U-BART 0.18 36.73 0.04 0.48
BART+SPL 0.15 30.95 0.55 0.36
3.1B-iii
U-GR 0.41 94.79 0.00 0.89
U-BART 0.24 55.00 0.01 0.68
BART+SPL 0.21 48.03 0.35 0.49
We also conducted a simulation study to evaluate the performance of BART+SPL for binary
outcomes. The simulated data structures utilized were similar to those described above. The data
and the results are described in Section A.2 of the Appendix. BART+SPL performed similar to or
better than the competing methods (U-GR and U-BART) in each of our simulations with N = 500.
However, even without non-overlap, BART probit can fail to provide improvements over parametric
methods when sample sizes are small to moderate, and thus we recommend that BART+SPL for
binary outcomes only be applied to large datasets (i.e., N ≥ 500).
3.2 BART+SPL with High Dimensional Covariates
One of the most widely-recognized limitations of BART, which was noted by its developers (Chip-
man et al., 2010), is its poor performance when the number of predictors, p, is large. The decline in
performance is most significant when many irrelevant predictors (i.e., predictors unrelated to the
outcome) are included. Thus, in this section, we seek to examine whether and how BART+SPL
should be applied in settings where the number of potential confounders is large. Although BART
has been extended to permit sparsity in the p > N setting (Linero, 2016), we do not consider the
p > N case here.
For these simulations, we let N = 500 and assign half of the sample to E = 1. We then
generate 10 confounders, 5 binary and 5 continuous. The binary confounders have distribution
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X1|E = 1, ..., X5|E = 1 ∼ Bernoulli(.45), X1|E = 0, ..., X5|E = 0 ∼ Bernoulli(.4), and the con-
tinuous confounders have distribution X6|E = 1, ..., X10|E = 1 ∼ N(2, 4), X6|E = 0, ..., X10|E =
0 ∼ N(1.3, 1). We consider the following three scenarios: only these 10 confounders are present
(simulation 3.2A), these 10 confounders as well as 25 randomly generated “potential confounders”
are present (simulation 3.2B), and these 10 confounders as well as 50 randomly generated “potential
confounders” are present (simulation 3.2C). Of course, in real applications, we often do not know
a priori which of the potential confounders are true confounders, hence we include them all in the
modeling. A propensity score is formed using predicted probabilities from the logistic regression
logit(P (Ei = 1)) = β0 + Ziβ, where Zi is a vector of the true and potential confounders. The
potential outcomes are generated so that they exhibit non-linear trends in the estimated propensity
score– Yi(0) = .5(X1i+X2i+X3i+X4i+X5i)+15(1+exp(−8X6i+1))−1+X7i+X8i+X9i+X10i−5
and Yi(1) = X1i +X2i +X3i +X4i +X5i − .5(X6i +X7i +X8i +X9i +X10i).
The features of these data are illustrated in Figure 6 in Section A.3 of the Appendix. The
simulations are designed to have a large RN in the right tail of the estimated propensity score, with
moderate non-linearity in the causal effect in the RN. The RO and RN are defined using tuning
parameters a = .1 and b = 7.
We simulate 1,000 datasets from each of the three scenarios described above. We apply both
BART+SPL and the untrimmed Gutman and Rubin spline method (GR) to each dataset. Results
are provided in Table 2.
Table 2: Absolute (Abs) bias, 95% credible interval coverage and mean square error (MSE) in
estimation of the population average causal effects in simulations from Section 3.2.
Simulation Setting Method Abs Bias Abs Bias (%) Coverage MSE
3.2A
GR 0.9801 5.6382 0.0320 13.1447
BART+SPL 0.5608 3.2198 0.9850 8.9744
3.2B
GR 0.5627 3.2363 0.4000 14.3195
BART+SPL 0.5574 3.2012 0.9740 8.4942
3.2C
GR 0.3640 2.0958 0.7280 16.0908
BART+SPL 0.6368 3.6591 0.9570 9.6857
These results reflect BART’s struggle in the presence of irrelevant predictors. When only the
10 true confounders are included in the modeling, BART+SPL outperforms GR and demonstrates
similar performance as in Section 3.1. However, when irrelevant predictors are introduced, GR’s bias
decreases while BART+SPL’s remains constant or increases. With 50 irrelevant predictors, GR’s
bias is substantially lower than BART+SPL’s (although, notably, its coverage and MSE remain
inferior). These results should serve as a warning that BART+SPL is only likely to improve on
existing methods in settings where the set of true confounders can be posited a priori with some
confidence.
3.3 Guidelines for Defining the RN
The simulation results in this section are intended to provide guidance on both the degree of
non-overlap that threatens BART’s performance and the degree of non-overlap that threatens
BART+SPL’s performance. They also suggest appropriate default specifications of tuning param-
eters a and b in the non-overlap definition. To impose strict control on the size of the RO and
RN, in these simulations we utilize a single confounder rather than a propensity score. Based on
the above simulations, we expect the performance of BART+SPL to be comparable with varying
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numbers of confounders, as long as few irrelevant covariates are included. Thus, the insights gained
from these simulations are likely to scale well to scenarios with larger confounder sets.
We let N = 500 and assign half of the sample to E = 1. We generate the confounder as
X|E = 1 ∼ N(2.5, 4), X|E = 0 ∼ N(v, w), where v and w control the degree of non-overlap.
Unlike in the previous simulations, in these we generate a single, fixed instance of the confounder and
simply add random noise to (a function of) it to create the potential outcomes for each simulation.
We consider two potential outcome scenarios, one of which produces data that are relatively simple
to model (with BART) while the other produces data that are challenging to model. The former,
which we label simulation 3.3A, is created by assigning Y (0) = 1.5 + X+(X
2/2!)
20 + N(0, 0.06) and
Y (1) = 1
1+e−(X−1) + N(0, 0.06) and the latter, which we call simulation 3.3B, by Y (0) = 1.5 +
X+(X2/2!)+(X3/3!)
20 + N(0, 0.06) and Y (1) =
1
1+e−(X−1) + N(0, 0.06).
In both simulation 3.3A and 3.3B, we achieve different degrees of non-overlap, primarily non-
overlap in the right tail of the confounder, by manipulating v and w. In order from least to most
non-overlap, we consider {v = 1.4, w = 1.96}, {v = 0.75, w = 1.44}, and {v = 0, w = 1}. Moreover,
in each scenario, we test the following three specifications of {a, b} in the overlap definition, in order
from most to least conservative: {a = 0.05 ∗ (range(X)), b = 10}, {a = 0.1 ∗ (range(X)), b = 10},
and {a = 0.15 ∗ (range(X)), b = 3}. Considering each combination of {v, w} and {a, b} leads to 9
different settings for each of simulation 3.3A and 3.3B, for a total of 18 simulation settings. The
proportion of the sample falling into the RN, denoted pi in these simulations ranges from pi = 2%
to pi = 34%. Of course, the impact of non-overlap on average causal effect estimates depends
not only on the proportion of the sample falling in the RN but also likely on the extremity of
the observations in the RN relative to the RO. In our simulations, as pi increases, the average
distance between observations in the RO and the RN also increases. An example dataset from both
simulation 3.3A and simulation 3.3B is presented in Figure 7 in Section A.3 of the Appendix.
Table 3: Absolute (Abs) bias, 95% credible interval coverage, and mean square error (MSE) in esti-
mation of the population average causal effects using BART+SPL and BART applied to simulation
3.3A. RO-1 refers to simulations with the RO defined as a = 0.05 ∗ (range(X)), b = 10, RO-2 refers
to simulations with the RO defined as a = 0.1 ∗ (range(X)), b = 10, and RO-3 refers to simulations
with the RO defined as a = 0.15 ∗ (range(X)), b = 3.
v, w Method pi Abs Bias Abs Bias (%) Coverage MSE
v = 1.4, w = 1.96
BART+SPL, RO-1 17 0.03 2.51 1.00 0.08
BART+SPL, RO-2 8 0.03 2.23 1.00 0.07
BART+SPL, RO-3 2 0.03 2.43 1.00 0.08
BART 0.03 2.98 0.81 0.09
v = 0.75, w = 1.44
BART+SPL, RO-1 24 0.05 4.14 1.00 0.09
BART+SPL, RO-2 14 0.04 3.44 1.00 0.08
BART+SPL, RO-3 6 0.05 4.06 1.00 0.09
BART 0.06 5.50 0.47 0.11
v = 0, w = 1
BART+SPL, RO-1 34 0.08 6.65 1.00 0.11
BART+SPL, RO-2 21 0.05 4.60 1.00 0.09
BART+SPL, RO-3 11 0.06 4.71 1.00 0.09
BART 0.07 6.28 0.59 0.11
We apply a standard BART (ignoring the non-overlap) and BART+SPL to 1, 000 simulated
datasets under each of the 18 conditions. Table 3 and Table 4 contain the results for simulations 3.3A
and 3.3B, respectively. While BART+SPL nearly always performs better in terms of each metric
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than BART, the most notable difference in the BART+SPL and BART results is the difference in
coverage probabilities, with BART+SPL consistently obtaining conservative coverage and BART’s
coverage deteriorating as the degree of non-overlap increases. Even when only 2% of the data falls
into the RN, BART’s coverage is unreliable. Thus, BART could provide misleading inference even
with small amounts of non-overlap.
BART+SPL’s coverage is conservative, but reliable, in all the simulations assessed, however
its bias tends to increase as the degree of non-overlap increases. Thus, it appears that, if some
bias in the point estimate can be tolerated, BART+SPL can be expected to provide conservative
inference in (non-pathological) scenarios with over 25% of the data in the RO. However, based on
the observation that BART+SPL’s bias is greater than 5% in simulation 3.3B under each overlap
definition with {v = 0.75, w = 1.44} and {v = 0, w = 1}, a more conservative option might be to
sacrifice the population-level estimand and performed a trimmed or weighted analysis when more
than 15% of the data falls in the RN.
Finally, we note that these simulations suggest that BART+SPL is quite robust to the specifica-
tion of a and b, as we see relatively small discrepancies in bias and coverage. However, some of the
results of 3.3B indicate that one should avoid defining the RO too conservatively, as discarding too
much information can lead to modest increases in bias. The moderate choice of a = 0.1 ∗ range(X)
and b = 10 provides the best results in most of the simulations, and we, therefore, recommend this
as the default specification.
Table 4: Absolute (Abs) bias, 95% credible interval coverage, and mean square error (MSE) in esti-
mation of the population average causal effects using BART+SPL and BART applied to simulation
3.3B. RO-1 refers to simulations with the RO defined as a = 0.05 ∗ (range(X)), b = 10, RO-2 refers
to simulations with the RO defined as a = 0.1 ∗ (range(X)), b = 10, and RO-3 refers to simulations
with the RO defined as a = 0.15 ∗ (range(X)), b = 3.
v, w Method pi Abs Bias Abs Bias (%) Coverage MSE
v = 1.4, w = 1.96
BART+SPL, RO-1 17 0.05 4.49 1.00 0.12
BART+SPL, RO-2 8 0.04 4.15 1.00 0.11
BART+SPL, RO-3 2 0.04 3.97 1.00 0.10
BART 0.05 4.69 0.57 0.12
v = 0.75, w = 1.44
BART+SPL, RO-1 24 0.07 6.27 1.00 0.14
BART+SPL, RO-2 14 0.06 5.72 1.00 0.13
BART+SPL, RO-3 6 0.06 5.83 1.00 0.12
BART 0.07 6.71 0.35 0.14
v = 0, w = 1
BART+SPL, RO-1 34 0.09 8.27 1.00 0.16
BART+SPL, RO-2 21 0.06 5.72 1.00 0.12
BART+SPL, RO-3 11 0.06 5.12 1.00 0.11
BART 0.06 5.67 0.74 0.12
4 The Effect of Natural Gas Compressor Stations on County-Level
Thyroid Cancer and Leukemia Mortality
We collected 2014 thyroid cancer and leukemia mortality rate estimates for each county in the US
from the Global Health Data Exchange. The data and methods used to develop these estimates
have been described previously (Mokdad et al., 2017). We also obtained the locations of NG com-
pressor stations from publicly available data complied by Oak Ridge National Laboratory (2017).
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While the data is not guaranteed to be complete, it is, to our knowledge, the most comprehensive
documentation of compressor station locations in existence, with 1,359 compressor station locations
verified using imagery. In order to test a causal hypothesis, we need to assume that exposure to
compressor station-related emissions preceded 2014 (the year for which cancer mortality rates are
observed) by at least the minimum latency period for thyroid cancer and leukemia. The CDC
reports the minimum latency period for thyroid cancer as 2.5 years and the minimum latency for
leukemia as 0.4 years (World Trade Center Health Program, 2015). Although the dataset does not
contain dates of origin for the compressor stations, it does contain peak operation dates. 84% of
the compressor stations in the dataset have peak operating dates in or before 2012; thus, it seems
reasonable to assume that most of the compressor stations in the dataset operated at least 2.5 years
prior to 2014.
Our county-level exposure variable is an indicator of whether a compressor station is present
in the county. We collected county-level demographic, socio-economic, and behavioral confounder
data from the American Community Survey 2014 5-year estimates (US Census Bureau, 2014) and
the 2014 County Health Rankings and Roadmaps (Robert Wood Johnson Foundation, 2014). Data
were accessed using Social Explorer. The confounders used are rate of primary care physicians,
percent of less than 65 year olds uninsured, percent diabetic, percent current smokers, percent of
people with limited access to healthy foods, percent obese, food environment index, population
density, percent male, percent less than age 55, percent white, average household size, percent with
bachelor’s degree or higher, percent unemployed, median household income, Gini index of inequality,
percent owner-occupied housing units, median rent as proportion of income, and average commute
time to work. All the data used in this analysis are publicly available, and the data and R code to
reproduce the analysis are posted on Github at https://github.com/rachelnethery/overlap.
We note that the sensitivity of this analysis to detect exposure effects will be low, because any
true health effects of exposure to compression station emissions is likely more spatially concentrated
than the county level. Although a higher spatial resolution analysis would be preferable, obtaining
important behavioral confounder data at a finer spatial resolution is challenging. In an effort to
improve the detectability of effects, we focus our analysis on roughly the mid-western region of the
US (counties with centroid longitudes between -110 and -90), where few other sources of pollution
exist compared to the coastal regions (Di et al., 2017). A focus on this region is also reasonable
because NG production has a longer history in this region compared to other US production regions,
likely leading to greater exposure.
We begin with a dataset of 1,309 counties, and, after discarding counties with any missing
confounders, are left with N=978 counties. 291 of these counties are exposed (i.e., contain at least
one compressor station) while 687 are unexposed. Table 7 in Section A.3 of the Appendix shows
the differences in the exposed and unexposed populations. Notably, exposed counties have, on
average, higher percent uninsured, lower population density, lower percent white, lower education,
and higher percent unemployment. We estimate a propensity score by applying a BART probit
with exposure status as the response and all the confounders as predictors. The histogram in
Figure 1 illustrates the non-overlap in the resulting propensity score, with the solid vertical lines
denoting the start of the intervals of non-overlap that are detected in each tail of the propensity
score using our overlap definition and a = 0.1 ∗ range(ξˆ) and b = 10. With these specifications,
12% of the sample falls into the RN. BART+SPL is needed to obtain population level causal effect
estimates in this setting.
The following outcome variables are considered: (1) 2014 thyroid cancer mortality rate, (2) the
change in thyroid cancer mortality rate from 1980 to 2014, (3) 2014 leukemia mortality rate, and
(4) the change in leukemia mortality rate from 1980 to 2014. The 2014 rates are log-transformed
prior to analysis. We analyze each outcome using both BART+SPL and trimmed BART. Counties
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Figure 1: Estimated propensity score histograms stratified by exposure status and overlaid. Bold
vertical lines represent the start of non-overlap intervals in both tails of the distribution.
in the trimmed sample are more urban and densely populated, on average, than the population
represented by the full sample (trimmed sample average population density is 108.40 per mi2
compared to 99.38 in the full sample).
Average causal effect estimates and 95% credible intervals from each analysis can be found
in Table 5. The BART+SPL analysis is estimating population average causal effects, and the
trimmed BART is estimating trimmed sample average causal effects. Only two of these analyses
find statistically significant effects of NG compressor stations– the trimmed BART analyses of the
change in thyroid cancer mortality rates from 1980 to 2014 and of the change in leukemia mortality
rates from 1980 to 2014. As discussed above, we must interpret these as significant effects only
in the trimmed sample, which is on average more urban than the population of interest. The
population-level estimates from BART+SPL have wider credible intervals for two reasons. First,
the additional marginalization over the confounders required to obtain population-level estimates
increases the variance. Second, to estimate at the population level, we must account for the
additional uncertainty induced by the non-overlap, which BART+SPL does by inflating variances
in the RN. With these wide credible intervals, evidence of an effect must be very compelling in order
to achieve statistical significance. However, we note that the point estimate from each analysis is
positive, indicating a harmful effect of compressor stations on health, and in each case the point
estimates are quite similar in the trimmed and untrimmed analyses.
In Table 8 and Table 9 in Section A.3 of the Appendix, we provide the results of two sensitivity
analyses using alternate specifications of a and b, one resulting in a larger RN and one in a smaller
RN. The BART+SPL results demonstrate little sensitivity to these choices, with point estimates
changing little and inference remaining the same in each analysis. This robustness agrees with
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Table 5: Average causal effects of natural gas compressor station presence on 2014 county-level thy-
roid cancer and leukemia mortality rates and the change in thyroid cancer and leukemia mortality
rates from 1980 to 2014.
Outcome Method Effect 95% CI
2014 Thyroid Rates
BART+SPL 0.001 -0.017, 0.020
BART 0.003 -0.007, 0.012
Change in Thyroid Rates 1980-2014
BART+SPL 0.992 -0.308, 2.237
BART 1.089 0.130, 2.038
2014 Leukemia Rates
BART+SPL 0.006 -0.013, 0.025
BART 0.005 -0.004, 0.014
Change in Leukemia Rates 1980-2014
BART+SPL 0.913 -0.361, 2.206
BART 0.988 0.014, 1.958
findings in simulated data in Section 3.3. The inference from the trimmed BART, however, is sen-
sitive to the a and b choices, with the significant leukemia effect being attenuated in one sensitivity
analysis and both significant effects being attenuated in the other. This sensitivity is not surprising,
given that changes in the observations trimmed correspond to changes in the estimand. Because
the trimmed BART is sensitive to these subjective choices, we should interpret the results with
caution.
The significant and near-significant findings presented here suggest that the health effects of
compressor station exposure is a topic that warrants further study with higher quality data. The
data utilized here have numerous limitations that could be improved upon by future studies. In
particular, an analysis at higher spatial resolution is needed in order to be able to detect geo-
graphically concentrated effects that may be washed out at the county level. Moreover, counties
with compressor stations may also be more likely to be located in NG production regions; thus,
an analysis at the county level may not be able to distinguish the effects of compressor station ex-
posure from the effects of NG drilling and production-related exposures. Finally, an investigation
of cancer diagnosis rates may be more informative about the possible dangers of NG compressor
station exposure than our investigation of cancer mortality rates. However, cancer diagnosis rates
are difficult to obtain across large geographic regions.
5 Discussion
In this paper, we have introduced a general definition of propensity score non-overlap and have
proposed a Bayesian modeling approach to estimate population average causal effects and corre-
sponding uncertainties in the presence of non-overlap. A novel feature of our proposed approach
is its separation of the tasks of estimating causal effects in the region of overlap and the region of
non-overlap and its delegation of these tasks to two distinct models. A BART model is selected to
perform estimation of individual causal effects in the region of overlap where there is strong data
support, thanks to its non-parametric nature, its ability to capture heterogeneous effects, and its
strong predictive capacity. In the region of non-overlap, where reliance on model specification is
required to estimate causal effects, individual causal effects are estimated by extrapolating trends
from the region of overlap via a parametric spline model. This approach, which we call BART+SPL,
can be applied to data with either continuous or binary outcomes and can be implemented in a
fully Bayesian manner, so that uncertainties from both stages are captured.
We demonstrated via simulations that BART+SPL outperforms both stand-alone BART and
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stand-alone spline causal inference approaches in estimation of population average causal effects
under a wide range of conditions involving propensity score non-overlap. However, due to BART’s
limitations in high dimensional settings, BART+SPL may give more biased results than existing
methods when many irrelevant predictors are present.
While we have focused primarily on the use of our overlap definition with BART+SPL, it can
also be used to define the RO for trimming, and it may provide a more transparent and repro-
ducible approach than trimming by eye. The rich causal inference literature on caliper selection
for matching procedures may provide insight on how to specify a and b for the use of this overlap
definition with trimming (Stuart, 2010; Lunt, 2014). However, as demonstrated by the trimmed
BART results in Section 4, our overlap definition is unlikely to produce an interpretable trimmed
estimand. Therefore, other strategies that prioritize the interpretability of the resulting estimand
may be preferable, such as overlap weighting (Li et al., 018a).
We again note that BART+SPL is intended to handle finite sample non-overlap only, because
the appropriateness of estimating population average causal effects may be called into question when
the population exhibits non-overlap. When non-overlap is a finite sample feature, it will disappear
asymptotically. It is for this reason that we have avoided discussions of double robustness. Because
double robustness is an asymptotic property, and BART+SPL is a finite sample method, we cannot
make claims about double robustness in the classic sense. However, we have demonstrated in
simulations that, relative to the competing methods considered, BART+SPL is most robust to
both outcome and propensity score model misspecification in the presence of non-overlap.
A key contribution of our work is the introduction of a tuning parameter used to inflate the
variance of causal effect estimates in regions of poor data support, so that this variance adequately
reflects the high estimation uncertainty in such regions. We have recommended a choice of tuning
parameter that linearly increases the variance as the distance into the RN increases, and the scale
of these increases is tailored to correspond reasonably to the scale of the estimated causal effects in
regions of good data support. Simulation results demonstrated that the resulting credible intervals
are much more reliable than those produced by competing methods in the presence of non-overlap.
However, in “simple” scenarios (i.e., scenarios where trends in the causal effects in the RN are
easily predictable based on trends in the RO), this tuning parameter can produce conservative
uncertainties.
Although to our knowledge, the use of Gaussian Process Regression (GPR) for causal inference
has not previously been discussed in the literature, there are clear connections between the features
of our approach and the features of GPR, thus a comparison of the two methods is warranted.
GPR is a traditionally Bayesian non-parametric regression technique that employs kernel functions
to interpolate and predict the outcome at unobserved points. It naturally accommodates non-
linearities and identifies regions of poor data support and inflates uncertainties in those regions.
While these features might make it an attractive and parsimonious approach to causal inference
in the presence of non-overlap, BART+SPL provides the following three advantages over GPR
that may render it more appealing, particularly to applied scientists: (1) less sensitivity to tuning
choices, (2) more intuitive tuning parameters, and (3) greater computational scalability. BART is
highly regarded for its strong and consistent performance under default tuning specifications, and,
in Section 3.3, BART+SPL also demonstrated little sensitivity to tuning choices. The results of
GPR are known to be highly sensitive to the choice of kernel and tuning parameters. Similarly,
GPR’s tuning parameters are often difficult to understand, as they are embedded in kernel functions
within covariance matrices; therefore, tuning typically requires guess-and-check work. BART+SPL
involves tuning parameters with straightforward interpretations relating to the definition of ade-
quate data support. Finally, GPR requires manipulation of a N × N covariance matrix in each
MCMC iteration, making it time-consuming or infeasible with large datasets, while BART+SPL is
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much more scalable.
Our work introduces an exciting direction for methodological developments in the context of
causal inference with propensity score non-overlap. For instance, other machine learning methods
(Cristianini and Shawe-Taylor, 2000; Breiman, 2001; Schmidhuber, 2015) may also have properties
that make them well-suited to handle non-overlap, and the replacement of BART with one of these
other methods could be explored. Moreover, the limitations of BART in high dimensions provide
an opportunity for improvement on our method. Improvements might be made through the use of
other machine learning methods, through the integration of sparsity-inducing priors with BART as
developed by Linero (2016), or through the addition of pre-processing procedures to first identify a
minimal confounder set. In the spirit of Bayesian Adjustment for Confounding (Wang et al., 2012),
propensity score model and outcome model variable selection could be accomplished simultaneously.
For instance, a propensity score model and a BART+SPL model could be fit jointly, both utilizing
sparsity inducing priors, where the propensity score model priors are informed by the strength of
the relationship between the outcome and each covariate, and the BART+SPL model priors are
informed by the strength of the relationship between the exposure and each covariate. Finally,
theoretical results remain to be developed for methods that perform causal effect estimation in the
RO and RN using distinct models. These could be avenues for future work.
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A Appendix
A.1 BART+SPL MCMC Sampling Scheme for Continuous Outcomes
BART+SPL can be implemented via an MCMC sampling scheme that is easily executed in R
software (R Core Team, 2016) with the help of the existing dbarts package (Chipman et al., 2010)
for drawing samples from a BART. The full conditional distribution of the parameters in a given
tree in the BART,
p(Tj ,Mj |YobsO , σ2B, T1, ..., Tj−1, Tj+1, ..., TJ ,M1, ...,Mj−1,Mj+1, ...,MJ), depends only on the ob-
served data and the other tree parameters only through the partial residuals V Oj = Y
obs
O −∑
l 6=j g(XO; Tl,Ml). Invoking this simplification, BART can be fit using a technique called Bayesian
backfitting or backfitting MCMC (Hastie and Tibshirani, 2000), where the MCMC samples from
a given tree are drawn while treating the parameters from all other trees as constant. We outline
the steps for obtaining MCMC samples from BART+SPL below, assuming the default BART prior
distributions recommended in Chipman et al. (2010) and non-informative Normal-Inverse Gamma
priors for the spline model. This sampling scheme assumes that only one smoothing stage model is
fit, i.e., the RN contains observations from only one exposure group; however, if the RN contains
observations from both exposure groups and two splines are needed, steps (5) and (6) can easily
be repeated for a second spline model. We assume that each of the BART and spline parameters
has been initialized, so that we begin with
{
T (0)j ,M(0)j , σ2B(0),β(0), σ2S(0)
}
.
For m = 1, ...,M ,
1. For tree j, (j = 1, ..., J)
(a) Draw T (m)j from p(Tj |V (m−1)Oj , σ2B(m−1)) using the Metropolis Hastings algorithm de-
scribed by Chipman et al. (1998)
(b) DrawM(m)j from p(Mj |V (m−1)Oj , σ2B(m−1), T (m)j ) through a random sample from the Nor-
mal distribution
2. Draw σ2B
(m)
from p(σ2B|YobsO , T (m)1 , ..., T (m)J ,M(m)1 , ...,M(m)J ) through a random sample from
an Inverse-Gamma distribution
3. Draw YmisO
(m)
from p(YmisO |YobsO , T (m)1 , ..., T (m)J ,M(m)1 , ...,M(m)J , σ2B(m)) through a random
sample from a Normal distribution
4. Form ∆
(m)
O as the appropriate linear combination of Y
obs
O and Y
mis
O
(m)
5. Draw β(m) from p(β|∆(m)O , σ2S(m− 1)) through a random sample from the Normal distribu-
tion
6. Draw σ2S
(m)
from p(σ2S |∆(m)O ,β(m)) through a random sample from an Inverse-Gamma distri-
bution
7. Draw ∆
(m)
O⊥ from p(∆O⊥ |∆
(m)
O ,β
(m), σ2S
(m)
, τq) through a random sample from a Normal
distribution
8. Draw ∆
(m)
P by executing B iterations of the Bayesian bootstrap on
{
∆˜
(m)
O , ∆˜
(m)
O⊥
}
and ran-
domly selecting one of the B bootstrap sample averages
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A.2 Simulations with Binary Outcomes
In simulations involving a binary outcome, we again consider scenarios using the true propensity
score (2A) and simulations using a misspecified propensity score estimate (2B). In 2A, we let N , E,
X1, X2, and ξ be specified exactly as in simulation 3.1A of the main text. We relate the confounders
to the potential outcomes in the following way: logit(P (Yi(1) = 1)) = exp(0.25X2i) + 0.5X1iX2i
and logit(P (Yi(0) = 1)) = 0.2X
3
2i + 0.25X1i. To obtain binary outcomes, we simulate Yi(1) ∼
Bernoulli(P (Yi(1) = 1)) and Yi(0) ∼ Bernoulli(P (Yi(0) = 1)). In 2B, N , E, X1, X2, and ξˆ
are specified exactly as in simulation 3.1B of the main text, and we let logit(P (Yi(1) = 1)) =
3(1 + exp(−8X2i + 1))−1 + 0.25X1i − 2 and logit(P (Yi(0) = 1)) = .85(X2i − 2) + (X2i − 2)2.
As in Section 3.1 of the main text, the resulting simulated datasets exhibit non-overlap in the
right tail of the propensity score, and we can control the severity of the non-overlap through the
c parameter in the distribution of X2. Again, we will ignore any small intervals of non-overlap
(containing less than 10 observations) that may occur due to randomness outside the right tail of
the propensity score. We consider c = 0, c = 0.35, and c = 0.7, which yield data with properties
similar to those of the simulations described in Section 3.1 of the main text. A sample dataset under
each of these conditions is illustrated in Figure 4 in Section 3 of the Supplementary Materials.
We implement BART+SPL, untrimmed GR for binary outcomes (U-GR), and untrimmed
BART probit (U-BART) on each of 1,000 simulated datasets under each condition. The results
appear in Table 6. All three methods perform similarly in simulation 2A; however, BART+SPL
provides substantial gains in bias, coverage, and MSE in simulation 2B. We note that, even without
non-overlap, BART probit can fail to provide improvements over parametric methods when sam-
ple sizes are small to moderate (i.e., we have found mediocre performance in some datasets with
N = 500), and thus we recommend that BART+SPL for binary outcomes only be applied to large
datasets.
Table 6: Absolute (Abs) bias, 95% credible interval coverage and mean square error (MSE) in
estimation of the population average causal effects in simulations from Section 2.
Simulation Setting Method Abs Bias Abs Bias (%) Coverage MSE
2Ai
U-GR 0.03 27.30 0.69 0.01
U-BART 0.03 25.73 0.94 0.01
BART+SPL 0.03 25.25 0.96 0.01
2Aii
U-GR 0.03 31.01 0.70 0.01
U-BART 0.03 28.17 0.97 0.01
BART+SPL 0.03 28.17 0.98 0.01
2Aiii
U-GR 0.04 38.88 0.67 0.01
U-BART 0.03 34.18 0.95 0.01
BART+SPL 0.03 35.25 0.98 0.01
2Bi
U-GR 0.07 81.83 0.38 0.10
U-BART 0.05 56.78 0.90 0.05
BART+SPL 0.04 47.50 0.95 0.04
2Bii
U-GR 0.08 102.09 0.35 0.10
U-BART 0.05 67.91 0.88 0.06
BART+SPL 0.04 54.03 0.98 0.04
2Biii
U-GR 0.10 132.34 0.28 0.10
U-BART 0.06 85.29 0.83 0.06
BART+SPL 0.05 62.46 0.99 0.04
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A.3 Supplementary Tables and Figures
0 1 ξ(1)  ξ(𝑁)
𝑂
=  ξ𝑖 for 𝐸𝑖 = 0
=  ξ𝑖 for 𝐸𝑖 = 1
𝑎 =
𝑂⊥
𝑏 = 2
(a)
0 1 ξ(1)  ξ(𝑁)
𝑂
=  ξ𝑖 for 𝐸𝑖 = 0
=  ξ𝑖 for 𝐸𝑖 = 1
𝑎 =
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𝑏 = 2
(b)
0 1 ξ(1)  ξ(𝑁)
=  ξ𝑖 for 𝐸𝑖 = 0
=  ξ𝑖 for 𝐸𝑖 = 1
𝑎 =
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𝑂
(c)
Figure 2: Examples of several types of propensity score non-overlap regions that can be captured
by our definition. The definition relies on user-specified parameters a and b. a is an interval length
and b is a portion of the sample size, representing the number of estimated propensity scores from
each exposure group that must lie sufficiently close, i.e., within an interval of length a, to any given
point in order for the point to be added to the RO. Figure (a) demonstrates non-overlap in the
tail of the distribution, Figure (b) demonstrates non-overlap in the interior of the distribution, and
Figure (c) demonstrates multiple intervals of non-overlap.
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Figure 3: Examples of the simulated data for simulation 3.1A (a) and simulation 3.1B (b). The appearance of two separate trend lines
in the figures is due to the use of one binary confounder and one continuous confounder for data generation.
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Figure 4: Estimates of Average Causal Effects from simulation 3.1A (a) and simulation 3.1B (b).
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Figure 5: Examples of the simulated data for simulation 2A (a) and simulation 2B (b) of the Appendix. The appearance of two separate
trend lines in the figures is due to the use of one binary confounder and one continuous confounder for data generation.
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Figure 6: Example dataset from simulation 3.2B where p = 35, i.e., 10 true confounders and 25
randomly generated predictors.
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Figure 7: Example datasets from simulation 3.3A (a) and simulation 3.3B (b).
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Table 7: Summary of outcome and confounder variables overall and stratified by exposure status.
All rates are per 100,000 population.
Total (N=978) Unexposed (N=687) Exposed (N=291)
Variable Mean SD Mean SD Mean SD
2014 Thyroid Rate 0.55 0.06 0.55 0.06 0.56 0.05
Change Thyroid Rate 1980-2014 1.71 8.03 1.16 7.67 2.99 8.71
2014 Leukemia Rate 9.64 0.90 9.66 0.90 9.6 0.89
Change Leukemia Rate 1980-2014 -4.29 8.54 -4.26 8.24 -4.36 9.21
Rate of Primary Care Physicians 801.39 1330.09 773.65 1398.35 866.87 1152.66
Percent Uninsured 17.74 5.53 17.36 5.48 18.64 5.55
Percent Diabetic 83.02 8.14 83.33 8.07 82.29 8.29
Percent Current Smokers 20.51 6.17 20.33 6.49 20.95 5.33
Percent Healthy Food Access 10.18 8.19 10.33 8.67 9.82 6.95
Percent Obese 28.43 5.19 28.45 5.25 28.40 5.05
Food Environment Index 7.31 1.32 7.33 1.32 7.27 1.30
Population Density 99.38 332.66 106.05 372.07 83.62 212.12
Percent Male 50.10 1.89 50.10 1.83 50.11 2.05
Percent <55 69.61 6.17 68.88 6.46 71.36 5.01
Percent White 84.88 16.39 86.16 15.77 81.86 17.42
Average Household Size 2.50 0.25 2.47 0.25 2.56 0.26
Percent ≥ Bachelors Degree 20.01 7.80 20.36 8.19 19.19 6.74
Percent Unemployed 7.00 3.69 6.80 3.60 7.48 3.84
Median Household Income 46296 10436 46100 10489 46759 10314
Gini Index of Inequality 0.44 0.03 0.44 0.03 0.44 0.04
Percent Own Home 71.85 7.44 72.00 7.63 71.48 6.97
Median Rent, Proportion Income 27.43 4.43 27.28 4.41 27.76 4.45
Average Commute Time 21.28 5.30 21.08 5.34 21.75 5.19
Table 8: Average causal effects of natural gas compressor station presence on 2014 county-level thy-
roid cancer and leukemia mortality rates and the change in thyroid cancer and leukemia mortality
rates from 1980 to 2014. Sensitivity analysis with a = .05 ∗ range(ξˆ) and b = 10.
Outcome Method Effect 95% CI
2014 Thyroid Rates
BART+SPL -0.001 -0.030, 0.028
BART 0.002 -0.008, 0.011
Change in Thyroid Rates 1980-2014
BART+SPL 1.020 -0.531, 2.616
BART 1.039 0.050, 2.019
2014 Leukemia Rates
BART+SPL 0.003 -0.029, 0.034
BART 0.005 -0.004, 0.015
Change in Leukemia Rates 1980-2014
BART+SPL 0.963 -0.655, 2.557
BART 0.886 -0.140, 1.909
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Table 9: Average causal effects of natural gas compressor station presence on 2014 county-level thy-
roid cancer and leukemia mortality rates and the change in thyroid cancer and leukemia mortality
rates from 1980 to 2014. Sensitivity analysis with a = .15 ∗ range(ξˆ) and b = 3.
Outcome Method Effect 95% CI
2014 Thyroid Rates
BART+SPL 0.003 -0.008, 0.014
BART 0.002 -0.007, 0.012
Change in Thyroid Rates 1980-2014
BART+SPL 0.980 -0.141, 2.127
BART 0.939 -0.047, 1.884
2014 Leukemia Rates
BART+SPL 0.003 -0.008, 0.015
BART 0.002 -0.007, 0.012
Change in Leukemia Rates 1980-2014
BART+SPL 0.851 -0.316, 2.001
BART 0.864 -0.110, 1.836
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